Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. AVIENT MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the information.

For manufacturers and producers that need to work better and faster, proprietary Aquamix custom formulations are our business-as-usual solutions for the world’s leading companies. Our Aquamix dispersions and emulsions are formulated and manufactured in our modern facility and laboratory located in Massillon, Ohio. Our Aquamix dispersions and emulsions are formulated and manufactured in our modern facility and laboratory located in Massillon, Ohio.

Pune, Maharashtra - 412 220 India Hold this Opinion Statement No. 770146 / 2022 The Organization has demonstrated that they have followed the Good Manufacturing Practices with reference to IPEC -PQG-GMP requirements applicable to Excipients used in pharma products for the following Business activity: “Research and Development, Manufacture of Color additives, Concentrates and Specialty Formulations for intended use in pharma and other industries”.

You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

Page 102 Critical Imperatives – Medium to Long Term • Continue cultural and paradigm shift from commodity compounder to collaborative formulator as One PolyOne • Accelerate innovation and leverage megatrends to improve our mix of business with higher-margin improve our mix of business with higher-margin specialty products • Increase specialty contribution and advance globalization via acquisitions • Drive relentless execution and creative innovation as key competitive differentiators Page 103 2011 Proforma ColorMatrix 2015 Target “Where we are” “Where we expect to be” 1) Operating Income % Specialty 8.9% PP&S 7.2% 12 – 16% 9 – 12% Elevating our Expectations and Yours PP&S 7.2% Distribution 5.6% 2) Specialty Platform % of Operating Income 50% 3) ROIC* (after-tax) 10% 4) Adjusted Annual EPS Growth 3 yr CAGR = 71% 9 – 12% 6 – 7.5% 65 – 75% 15% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 104

SBC compounds offer good economics and formulation flexibility meeting the end use performance requirements. Formulation Development Based on the market feedback, the developmental TPE needed to meets three major general requirements;, clarity, heat resistance and softness.